Adherence to dosing schedule of denosumab therapy for osteoporosis during COVID-19 lockdown: an electronic medical record and pharmacy claims database study from Asia-Reference-Cited by-同舟云学术

Adherence to dosing schedule of denosumab therapy for osteoporosis during COVID-19 lockdown: an electronic medical record and pharmacy claims database study from Asia

Published:2021-08-21 Issue:1 Volume:33 Page:251-261
ISSN:0937-941X
Container-title:Osteoporosis International
language:en
Short-container-title:Osteoporos Int

Author:

Chandran Manju^ORCID,Hao Ying,Kwee Ann Kerwen,Cheen Mcvin Hua Heng,Chin Yun Ann,Ng Valerie Yun Ting

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s00198-021-06085-0.pdf

Reference35 articles.

1. Chandran M, Lau TC, Gagnon-Arpin I, Dobrescu A, Li W, Leung MYM et al (2019) The health and economic burden of osteoporotic fractures in Singapore and the potential impact of increasing treatment rates through more pharmacological options. Arch Osteoporos 14(1):114

2. Chandran M, Mitchell PJ, Amphansap T, Bhadada SK, Chadha M, Chan DC et al (2021) Development of the Asia Pacific Consortium on Osteoporosis (APCO) Framework: clinical standards of care for the screening, diagnosis, and management of osteoporosis in the Asia-Pacific region. Osteoporos Int 32(7):1249–1275

3. Chau YT, Nashi N, Law LSC, Goh RKH, Choo SX, Seetharaman SK (2020) Undertreatment of osteoporosis following hip fracture: a retrospective, observational study in Singapore. Arch Osteoporos 15(1):141

4. Lyu H, Zhao SS, Yoshida K, Tedeschi SK, Xu C, Nigwekar SU et al (2020) Delayed denosumab injections and bone mineral density response: an electronic health record-based study. J Clin Endocrinol Metab 105(5):1435–1444

5. Tsourdi E, Zillikens MC, Meier C, Body JJ, Gonzalez Rodriguez E, Anastasilakis AD et al (2020) Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS. J Clin Endocrinol Metab 106(1):264–281. https://doi.org/10.1210/clinem/dgaa756

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The evaluation of an osteoporosis medication management service in community pharmacy, a cohort study;Exploratory Research in Clinical and Social Pharmacy;2024-09

2. On-time denosumab dosing recovered rapidly during the COVID-19 pandemic, yet remains suboptimal;JBMR Plus;2024-03-28

3. The interruption of romosozumab treatment during COVID lockdown among US post-menopausal women enrolled in Medicare;Bone;2024-01

4. Impact of the COVID-19 Pandemic on Adherence to Denosumab Therapy: A Single Center Study;Asian Spine Journal;2023-10-31

5. Drug adherence and treatment duration for denosumab and mortality risk among hip fracture patients;Osteoporosis International;2023-07-19